On Friday, Surmodics, Inc (NASDAQ: SRDX) opened higher 0.66% from the last session, before settling in for the closing price of $36.64. Price fluctuations for SRDX have ranged from $25.17 to $42.44 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.69%. Company’s average yearly earnings per share was noted 25.00% at the time writing. With a float of $13.71 million, this company’s outstanding shares have now reached $14.32 million.
Let’s determine the extent of company efficiency that accounts for 389 employees. In terms of profitability, gross margin is 65.55%, operating margin of -4.48%, and the pretax margin is -5.95%.
Surmodics, Inc (SRDX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Surmodics, Inc is 4.10%, while institutional ownership is 83.91%. The most recent insider transaction that took place on Nov 26 ’24, was worth 276,453. In this transaction Chief Financial Officer of this company sold 7,009 shares at a rate of $39.44, taking the stock ownership to the 70,350 shares. Before that another transaction happened on Nov 26 ’24, when Company’s Officer proposed sale 7,009 for $39.44, making the entire transaction worth $276,453.
Surmodics, Inc (SRDX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 25.00% per share during the next fiscal year.
Surmodics, Inc (NASDAQ: SRDX) Trading Performance Indicators
Check out the current performance indicators for Surmodics, Inc (SRDX). In the past quarter, the stock posted a quick ratio of 3.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach 0.28 in one year’s time.
Technical Analysis of Surmodics, Inc (SRDX)
Looking closely at Surmodics, Inc (NASDAQ: SRDX), its last 5-days average volume was 0.54 million, which is a jump from its year-to-date volume of 0.39 million. As of the previous 9 days, the stock’s Stochastic %D was 37.00%. Additionally, its Average True Range was 0.82.
During the past 100 days, Surmodics, Inc’s (SRDX) raw stochastic average was set at 37.69%, which indicates a significant decrease from 38.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.10% in the past 14 days, which was higher than the 15.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.04, while its 200-day Moving Average is $37.95. However, in the short run, Surmodics, Inc’s stock first resistance to watch stands at $37.22. Second resistance stands at $37.57. The third major resistance level sits at $38.19. If the price goes on to break the first support level at $36.25, it is likely to go to the next support level at $35.63. Now, if the price goes above the second support level, the third support stands at $35.28.
Surmodics, Inc (NASDAQ: SRDX) Key Stats
There are currently 14,294K shares outstanding in the company with a market cap of 527.17 million. Presently, the company’s annual sales total 126,080 K according to its annual income of -11,540 K. Last quarter, the company’s sales amounted to 33,230 K and its income totaled -3,450 K.
